Recombinant E. coli Biocatalyst for L-Aspartic Acid Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current industrial processes for producing L-aspartic acid from maleic acid are inefficient due to high temperature and pressure requirements, environmental pollution, and low yield, with limited studies on whole-cell biocatalysis methods due to challenges with maleate cis-trans isomerase stability and enzyme activity.
Innovation Solution
A recombinant strain co-expressing maleate cis-trans isomerase and L-aspartate lyase is engineered to catalyze the conversion of maleic acid to L-aspartic acid, using E. coli as the host and optimizing enzyme expression to achieve high conversion rates.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional industrial process with inorganic catalyst and strong acid is used, then L-aspartic acid can be produced, but high temperature and pressure are required causing equipment complexity and environmental pollution
Solution Approach 1:
The patent replaces the traditional mechanical/chemical catalysis system (inorganic catalysts, strong acids, high temperature, high pressure) with a biological catalysis system (whole-cell biocatalysis using engineered E. coli expressing maleate cis-trans isomerase and L-aspartate lyase). This substitution eliminates the need for complex high-pressure equipment and harsh chemical conditions while maintaining high productivity for L-aspartic acid production.
Solution Approach 2:
The patent fundamentally changes the reaction parameters from extreme conditions (pH 1, high temperature, high pressure) to mild physiological conditions (neutral pH, ambient temperature and pressure). By using whole-cell biocatalysis, the reaction proceeds efficiently under gentle conditions, eliminating the need for specialized high-pressure equipment and reducing environmental pollution.
2Productivity
If traditional industrial process is used, then L-aspartic acid production is achieved, but intermediate product fumarate requires separation and purification causing yield loss
Solution Approach 1:
The patent implements a continuous enzymatic reaction pathway where maleic acid is converted to fumarate by maleate cis-trans isomerase, and fumarate is immediately converted to L-aspartic acid by L-aspartate lyase within the whole-cell system. This continuous action prevents fumarate accumulation and eliminates the need for intermediate separation and purification steps, thereby preventing yield loss.
Solution Approach 2:
The patent merges two separate enzymatic reactions (maleate isomerization and fumarate conversion) into a single integrated whole-cell biocatalytic system. By co-expressing both enzymes in engineered E. coli, the process combines the catalytic functions into one step, eliminating the need for separate purification stages and reducing substance loss.
3Productivity
If maleate cis-trans isomerase is used for whole-cell biocatalysis, then conversion rate can be improved, but enzyme stability and activity are poor making heterologous expression difficult
Solution Approach 1:
The patent uses the E. coli cellular machinery as an intermediary system to express and stabilize the maleate cis-trans isomerase enzyme. By utilizing the host cell's transcriptional and translational apparatus, along with appropriate promoters and expression vectors, the enzyme achieves stable expression and maintained activity within the whole-cell system, overcoming the heterologous expression difficulties.
Solution Approach 2:
The patent optimizes expression parameters including promoter strength, induction conditions, and growth temperature to enhance enzyme stability and activity. By adjusting these biological parameters, the maleate cis-trans isomerase maintains high catalytic activity and stability when expressed heterologously in E. coli, enabling effective whole-cell biocatalysis.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves a high conversion rate of 98% or more with complete reaction of maleic acid in 40-120 minutes, minimizing intermediate fumarate buildup and reducing environmental impact.
Implementation Method 1
catalyzing a substrate maleic acid by using a recombinant strain co-expressing maleate cis-trans isomerase and L-aspartate lyase
Implementation Method 2
co-expressing maleate cis-trans isomerase and L-aspartate lyase to produce L-aspartic acid from maleic acid
Data Source
AI summary
The invention relates to the technical field of bioengineering, and discloses a method for synthesizing L-aspartic acid with maleic acid by whole-cell biocatalysis. In the invention, a recombinant strain co-expressing maleate cis-trans isomerase and L-aspartate lyase is constructed, and engineered and optimized to produce L-aspartic acid from maleic acid with a high conversion rate by whole-cell catalyzing. Relatively inexpensive maleic acid is utilized by the recombinant strain to produce L-aspartic acid, where maleic acid is reacted completely in 40-120 min, there is almost no buildup of the intermediate fumaric acid, and the conversion rate is up to 98% or more.